Figure 1 (IMAGE)

Tohoku University

Figure 1

Caption

Schematic illustration of the B-LM-DMX-αCD25 nanoplatform design and its three synchronized therapeutic mechanisms: selective Treg depletion, photothermal-induced immunogenic cell death, and STING pathway activation for systemic antitumor immunity.
 

Credit

Eijiro Miyako

Usage Restrictions

Reporters may use these materials freely in news coverage with appropriate credit information.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.